Cantitate/Preț
Produs
Total produse
Vezi coșul
Tamoxifen: Pioneering Medicine in Breast Cancer de Philipp Y. Maximov

Tamoxifen: Pioneering Medicine in Breast Cancer: Milestones in Drug Therapy

Autor Philipp Y. Maximov, Russell E. McDaniel, V. Craig Jordan
en Limba Engleză Paperback – 8 feb 2015
Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the first drug targeted therapy in cancer to be successful. Tamoxifen targets the tumor estrogen receptor. The therapy is known to have saved the lives of millions of women over the past 40 years.
This monograph, written by V. Craig Jordan - known as the “father of tamoxifen” - and his Tamoxifen Team at the Georgetown University Washington DC, illustrates the journey of this milestone in medicine. It includes a personal interview with V. Craig Jordan about his four decades of discovery in breast cancer research and treatment. V. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a “failed morning after contraceptive” to become the “gold standard” for the treatment of breast cancer. He contributed to every aspect of tamoxifen application in therapeutics and all aspects of tamoxifen’s pharmacology. He discovered the selective estrogen receptor modulators (SERMs) and explored the new biology of estrogen-induced apoptosis.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 124278 lei  6-8 săpt.
  Springer – 8 feb 2015 124278 lei  6-8 săpt.
Hardback (1) 124896 lei  6-8 săpt.
  Springer – 6 aug 2013 124896 lei  6-8 săpt.

Din seria Milestones in Drug Therapy

  • 5% Gene Therapy for Autoimmune and Inflammatory Diseases
    Preț: 136920 lei
  • 5% Treatment of Psoriasis
    Preț: 84002 lei
  • 5% Valproate
    Preț: 36125 lei
  • 5% Modern Immunosuppressives
    Preț: 35507 lei
  • 5% Cognitive Enhancing Drugs
    Preț: 69115 lei
  • 5% Fluoroquinolone Antibiotics
    Preț: 70110 lei
  • 5% Glucocorticoids
    Preț: 63053 lei
  • 5% Drugs Targeting B-Cells in Autoimmune Diseases
    Preț: 107138 lei
  • 5% Atypical Antipsychotics
    Preț: 136688 lei
  • 5% Glucocorticoids
    Preț: 35417 lei
  • 5% Pharmacotherapy of Obesity
    Preț: 66733 lei
  • 5% Glutamate-based Therapies for Psychiatric Disorders
    Preț: 106213 lei
  • 5% Methotrexate
    Preț: 35079 lei
  • 5% HMG-CoA Reductase Inhibitors
    Preț: 68830 lei
  • 5% ACE Inhibitors
    Preț: 35472 lei
  • 5% COX-2 Inhibitors
    Preț: 106782 lei
  • 5% Recombinant Protein Drugs
    Preț: 106569 lei
  • 5% Proton Pump Inhibitors
    Preț: 124719 lei
  • 5% Antidepressants
    Preț: 62311 lei
  • 5% Treatment and Prevention of Malaria: Antimalarial Drug Chemistry, Action and Use
    Preț: 106907 lei
  • 5% Sildenafil
    Preț: 156062 lei
  • 5% Twenty Years of G-CSF: Clinical and Nonclinical Discoveries
    Preț: 138481 lei
  • 5% Aromatase Inhibitors
    Preț: 67167 lei
  • 5% Anxiolytics
    Preț: 68990 lei
  • 5% Cannabinoids as Therapeutics
    Preț: 174977 lei
  • 5% Calcium Channel Blockers
    Preț: 106870 lei
  • 5% PEGylated Protein Drugs: Basic Science and Clinical Applications
    Preț: 137597 lei
  • 5% Hepatitis Prevention and Treatment
    Preț: 106124 lei
  • 5% Bortezomib in the Treatment of Multiple Myeloma
    Preț: 69612 lei
  • 5% Erythropoietins and Erythropoiesis: Molecular, Cellular, Preclinical, and Clinical Biology
    Preț: 69824 lei
  • 5% Indacaterol: The First Once-daily Long-acting Beta2 Agonist for COPD
    Preț: 69488 lei
  • 5% Drugs for HER-2-positive Breast Cancer
    Preț: 105359 lei
  • 5% Combination Therapy of AIDS
    Preț: 106088 lei
  • 5% Influenza Virus Sialidase - A Drug Discovery Target
    Preț: 106162 lei
  • 5% Macrolide Antibiotics
    Preț: 107172 lei
  • 5% Tamoxifen: Pioneering Medicine in Breast Cancer
    Preț: 124896 lei

Preț: 124278 lei

Preț vechi: 130818 lei
-5% Nou

Puncte Express: 1864
Preț estimativ în valută:
23784€ • 25020$ • 19845£

Carte tipărită la comandă

Livrare economică 09-23 ianuarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783034807838
ISBN-10: 303480783X
Pagini: 224
Ilustrații: XXII, 199 p. 54 illus.
Dimensiuni: 155 x 235 x 12 mm
Greutate: 0.32 kg
Ediția:2013
Editura: Springer
Colecția Springer
Seria Milestones in Drug Therapy

Locul publicării:Basel, Switzerland

Public țintă

Research

Cuprins

Discovery and Pharmacology of Nonsteroidal Estrogens and Antiestrogens.- Tamoxifen Goes Forward Alone.- Metabolites of Tamoxifen as the Basis of Drug Development.- Adjuvant Therapy – The Breakthrough.- The Wisconsin Story in the 1980’s: Discovery of Target Site Specific Estrogen Action.- Carcinogenesis and Tamoxifen.- Chemoprevention: Cinderella waiting for the ball.- Tamoxifen and Raloxifene head to head: The STAR TRIAL.- Acquired resistance to Tamoxifen: back to the beginning.- The legacy of Tamoxifen.- Appendix: Four decades of discovery in breast cancer research and treatment – an interview with V. Craig Jordan by Marc Poirot.- Selected Awards that Recognize the Contribution of Tamoxifen and Raloxifene to Medicine.

Recenzii

From the book reviews:
“This is a book that had to be written. … This book should be available in every oncology department. The story will interest clinicians and laboratory scientists alike. It has both historical value and value as a guide that will illuminate the path to successful involvement in cancer research for younger cancer researchers.” (R. M. Lowenthal, Inflammopharmacology, Vol. 22 (3), June, 2014)
“This is a very well-written, readable book for anyone who has an interest in the prevention and treatment of breast cancer, ranging from those involved in drug discovery to those who are treating and taking care of patients with breast cancer. Likewise, anyone who has a loved one who has, or is at high risk for, breast cancer will find this an excellent read. … It is a well-done and interesting read.” (Thomas L. Pazdernik, Doody’s Book Reviews, November, 2013)

Textul de pe ultima copertă

Tamoxifen is a pioneering medicine for the treatment and prevention of breast cancer. It is the first drug targeted therapy in cancer to be successful. Tamoxifen targets the tumor estrogen receptor. The therapy is known to have saved the lives of millions of women over the past 40 years.
This monograph, written by V. Craig Jordan - known as the “father of tamoxifen” - and his Tamoxifen Team at the Georgetown University Washington DC, illustrates the journey of this milestone in medicine. It includes a personal interview with V. Craig Jordan about his four decades of discovery in breast cancer research and treatment. V. Craig Jordan was there for the birth of tamoxifen as he is credited for reinventing a “failed morning after contraceptive” to become the “gold standard” for the treatment of breast cancer. He contributed to every aspect of tamoxifen application in therapeutics and all aspects of tamoxifen’s pharmacology. He discovered the selective estrogen receptor modulators (SERMs) and explored the new biology of estrogen-induced apoptosis.

Caracteristici

The story of Tamoxifen written first-hand by the "father of tamoxifen" A personal journey through four decades of discovery that changed women’s health Including an interview with the pioneer of the therapy Includes supplementary material: sn.pub/extras